TY - JOUR T1 - Acquired partial lipodystrophy and C3 glomerulopathy: Dysregulation of the complement system as a common mechanism JO - Nefrología (English Edition) T2 - AU - Corvillo,Fernando AU - López-Trascasa,Margarita SN - 20132514 M3 - 10.1016/j.nefroe.2018.04.002 DO - 10.1016/j.nefroe.2018.04.002 UR - https://www.revistanefrologia.com/en-acquired-partial-lipodystrophy-c3-glomerulopathy-articulo-S2013251418300609 AB - The activation of the alternative pathway of the complement is involved in the development of several renal diseases, such as atypical haemolytic uraemic syndrome and C3 glomerulopathy. In C3 glomerulopathy, a high percentage of patients have circulating levels of the autoantibody called C3NeF, which causes systemic dysregulation of the complement system. In some cases, the presence of this antibody has been related with abnormalities of adipose tissue, causing acquired partial lipodystrophy (Barraquer–Simons syndrome). Acquired partial lipodystrophy is an extremely rare disorder affecting the distribution of subcutaneous adipose tissue and that mainly onsets during childhood. These patients, in addition to possibly presenting with all the metabolic disorders associated with the adipose tissue defect, present with C3 hypocomplementemia and C3NeF and 25% have developed C3 glomerulopathy. Although it has been known for some time how the dysregulation of the complement system affects the kidneys, it remains unknown how it exactly affects adipose tissue; nevertheless, the relationship is quite clear. In this paper, we describe the connection between the complement system with the biology of the adipose tissue and its pathogenesis reflected from acquired partial lipodystrophy. ER -